secwatch.observer — SEC 8-K summary
======================================

Issuer:     RIGEL PHARMACEUTICALS INC (RIGL)
CIK:        0001034842
Form:       8-K
Filed at:   2022-11-29T23:59:59+00:00
Accession:  0001104659-22-122864
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Rigel Pharmaceuticals receives Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------------------

- Nasdaq notified Rigel on Nov 22, 2022 that its common stock bid price closed below $1.00 for 30 consecutive business days.
- Rigel has 180 calendar days, until May 22, 2023, to regain compliance by closing at $1.00 or more for at least 10 consecutive business days.
- If not compliant by May 22, Rigel may be eligible for an additional 180-day period if it meets other listing standards and intends to cure via reverse stock split.
- Failure to regain compliance could lead to delisting; Rigel may appeal a delisting determination.
- No immediate effect on Nasdaq listing; stock continues to trade under RIGL.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1034842/000110465922122864/0001104659-22-122864-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1034842/000110465922122864/tm2231482d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-122864

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer